The Food and Drug Administration (FDA) said Thursday that it is extending the compliance deadline for its far-reaching FSMA ...

A retrospective study found that cannabis users were six times as likely to have a heart attack compared to non-users, while ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted the public on falsified Oxycontin 80mg ...

Under federal law, device makers must submit adverse event reports they receive from patients to the FDA’s Manufacturer And ...

The latest trend in treating hair loss may sound familiar — essentially, it’s a repurposed drug first popularized in the ...

The agency said the issue of the falsified medicine was reported to the World Health Organisation (WHO) by the genuine ...

MacroGenics (NASDAQ: MGNX) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...

Amtagvi® and its accompanying design marks, Proleukin®, Iovance®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously a ...

Laromestrocel (Lomecel-B™) has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for Alzheimer's disease ...

Virginia is expected to begin shield many past criminal convictions — including certain lower-level felonies — from public ...